DOI QR코드

DOI QR Code

Decrease of Protease-Resistant PrPSc Level in ScN2a Cells by Polyornithine and Polyhistidine

  • Waqas, Muhammad (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University) ;
  • Trinh, Huyen Trang (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University) ;
  • Lee, Sungeun (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University) ;
  • Kim, Dae-hwan (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University) ;
  • Lee, Sang Yeol (Department of Life Science, Gachon University) ;
  • Choe, Kevin K. (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University) ;
  • Ryou, Chongsuk (Department of Pharmacy and Institute of Pharmaceutical Science & Technology, Hanyang University)
  • 투고 : 2018.07.24
  • 심사 : 2018.10.22
  • 발행 : 2018.12.28

초록

Based on previous studies reporting the anti-prion activity of poly-${\text\tiny{L}}$-lysine and poly-${\text\tiny{L}}$-arginine, we investigated cationic poly-${\text\tiny{L}}$-ornithine (PLO), poly-${\text\tiny{L}}$-histidine (PLH), anionic poly-${\text\tiny{L}}$-glutamic acid (PLE) and uncharged poly-${\text\tiny{L}}$-threonine (PLT) in cultured cells chronically infected by prions to determine their anti-prion efficacy. While PLE and PLT did not alter the level of $PrP^{Sc}$, PLO and PLH exhibited potent $PrP^{Sc}$ inhibition in ScN2a cells. These results suggest that the anti-prion activity of poly-basic amino acids is correlated with the cationicity of their functional groups. Comparison of anti-prion activity of PLO and PLH proposes that the anti-prion activity of poly-basic amino acids is associated with their acidic cellular compartments.

키워드

참고문헌

  1. Prusiner SB. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383. https://doi.org/10.1073/pnas.95.23.13363
  2. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, et al. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349-358. https://doi.org/10.1016/0092-8674(83)90168-X
  3. Aguzzi A, Lakkaraju AKK, Frontzek K. 2018. Toward therapy of human prion diseases. Annu. Rev. Pharmacol. Toxicol. 58: 331-351. https://doi.org/10.1146/annurev-pharmtox-010617-052745
  4. Solassol J, Crozet C, Perrier V, Leclaire J, Beranger F, Caminade A-M, et al. 2004. Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J. Gen. Virol. 85: 1791-1799. https://doi.org/10.1099/vir.0.19726-0
  5. Cordes H, Boas U, Olsen P, Heegaard PMH. 2007. Guanidino- and urea-modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non-cytotoxic conditions: dependence on dendrimer generation and surface charge. Biomacromolecules 8: 3578-3583. https://doi.org/10.1021/bm7006168
  6. Supattapone S, Nguyen H-OB, Cohen FE, Prusiner SB, Scott MR. 1999. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. USA 96: 14529-14534. https://doi.org/10.1073/pnas.96.25.14529
  7. Supattapone S, Wille H, Uyechi L, Safar J, Tremblay P, Szoka FC, et al. 2001. Branched polyamines cure prioninfected neuroblastoma cells. J. Virol. 75: 3453-3461. https://doi.org/10.1128/JVI.75.7.3453-3461.2001
  8. Lim Y-b, Mays CE, Kim Y, Titlow WB, Ryou C. 2010. The inhibition of prions through blocking prion conversion by permanently charged branched polyamines of low cytotoxicity. Biomaterials 31: 2025-2033. https://doi.org/10.1016/j.biomaterials.2009.11.085
  9. Jackson KS, Yeom J, Han Y, Bae Y, Ryou C. 2013. Preference toward a polylysine enantiomer in inhibiting prions. Amino Acids 44: 993-1000. https://doi.org/10.1007/s00726-012-1430-8
  10. Ryou C, Titlow WB, Mays CE, Bae Y, Kim S. 2011. The suppression of prion propagation using poly-l-lysine by targeting plasminogen that stimulates prion protein conversion. Biomaterials 32: 3141-3149. https://doi.org/10.1016/j.biomaterials.2011.01.017
  11. Titlow WB, Waqas M, Lee J, Cho JY, Lee SY, Kim DH, et al. 2016. Effect of polylysine on scrapie prion protein propagation in spleen during asymptomatic stage of experimental prion disease in mice. J. Microbiol. Biotechnol. 26: 1657-1660. https://doi.org/10.4014/jmb.1601.01057
  12. Waqas M, Lee H-M, Kim J , Telling G, Kim J-K, Kim D-H, et al. 2017. Effect of poly-L-arginine in inhibiting scrapie prion protein of cultured cells. Mol. Cell. Biochem. 428: 57-66. https://doi.org/10.1007/s11010-016-2916-6
  13. Waqas M, Jeong W-j, Lee Y-J, Kim D-H, Ryou C, Lim Y-b. 2017. pH-dependent in-cell self-assembly of peptide inhibitors increases the anti-prion activity while decreasing the cytotoxicity. Biomacromolecules 18: 943-950. https://doi.org/10.1021/acs.biomac.6b01816
  14. Xu Z, Adrover M, Pastore A, Prigent S, Mouthon F, Comoy E, et al. 2011. Mechanistic insights into cellular alteration of prion by poly-D-lysine: the role of H2H3 domain. FASEB J. 25: 3426-3435. https://doi.org/10.1096/fj.11-187534
  15. Bond VC, Wold B. 1987. Poly-L-ornithine-mediated transformation of mammalian cells. Mol. Cell. Biol. 7: 2286-2293. https://doi.org/10.1128/MCB.7.6.2286
  16. Ge H, Tan L, Wu P, Yin Y, Liu X, Meng H, et al. 2015. Poly-L-ornithine promotes preferred differentiation of neural stem/progenitor cells via ERK signalling pathway. Sci. Rep. 5: 15535. https://doi.org/10.1038/srep15535
  17. Lee ES, Na K, Bae YH. 2005. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 5: 325-329. https://doi.org/10.1021/nl0479987
  18. Scott MRD, Butler DA, Bredesen DE, Walchli M, Hsiao KK, Prusiner SB. 1988. Prion protein gene expression in cultured cells. Prot. Eng. 2: 69-76. https://doi.org/10.1093/protein/2.1.69
  19. Arnold JE, Tipler C, Laszlo L, Hope J, Landon M, Mayer RJ. 1995. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J. Pathol. 176: 403-411. https://doi.org/10.1002/path.1711760412